Stem-cell technology company Bio-Restorative Therapies Inc. named Gregory Lutz chief medical advisor for spine medicine, effective Feb. 20. In a newly created post, Lutz will help the firm prepare its investigational new drug/investigational device exemption for its brtxDISC non-surgical treatment for bulging and herniated lumbar discs. Lutz is associate professor for clinical rehabilitation medicine at Weill Medical College of Cornell University in New York, and an attending physician at the Hospital for Special Surgery.
Gregory Lutz, M.D., BioRestorative Therapies Inc